Edition:
United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

23.05USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$23.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
870,011
52-wk High
$33.00
52-wk Low
$13.60

Sabella, Lauren 

Ms. Lauren M. Sabella is Chief Commercial Officer of Acorda Therapeutics, Inc. Prior to that, from January 2010 to February 2015, she was our Executive Vice President, Commercial Development. Ms. Sabella was the Founder and Principal of Tugboat Consulting Group, an independent consulting practice assisting companies in the commercialization process. Ms. Sabella also served as Corporate Officer and VP of Commercial Development at Altus Pharmaceuticals from May 2006 to September 2008, with responsibility for all aspects of commercialization. Prior to joining Altus, Ms. Sabella was employed by Boehringer Ingelheim Pharmaceuticals for 18 years in positions of increasing responsibility. In her last role, she served as VP of Sales, Eastern Zone, where she led the successful sales launch of Spiriva and ran both Primary Care and Specialty Divisions, including Neurology, Urology and Cardio/Pulmonary. Prior to this role, she had over ten years of marketing experience where she led several product launches including Mobic, an NSAID which became a $1 billion brand. Ms. Sabella holds a B.B.A. from Hofstra University.

Basic Compensation

Total Annual Compensation, USD 446,885
Restricted Stock Awards, USD 227,505
Long-Term Incentive Plans, USD --
All Other, USD 385,724
Fiscal Year Total, USD 1,060,110

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen

3,433,220

Richard Batycky

--

David Lawrence

1,360,800

Andrew Blight

1,484,560

Jane Wasman

1,986,540

Burkhard Blank

3,521,550
As Of  30 Dec 2016